- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06839950
Sensory Profile and Early Clinical Signs of Calm Room Users (EVAL-APAISE)
This descriptive study aims primarily to characterize the sensory profile of patients in a closed psychiatric hospital unit who use a calming room.
The main questions it aims to answer are :
- Could sensory information processing disorders be the cause of distress and tension in these patients?
- Could users of the calming room present extreme sensory processing profiles, characterized by either hypersensitivity or hyposensitivity ?
Participants will answer a survey to determine their the sensory profile. Participants can already use the calming room as part of their regular medical care and they will answer surveys before and after each use.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Aude Paquet, PhD in Psychology
- Phone Number: +33 5-55-43-11-27
- Email: aude.paquet@ch-esquirol-limoges.fr
Study Locations
-
-
Nouvelle-Aquitaine
-
Limoges, Nouvelle-Aquitaine, France, 87025
- Recruiting
- Esquirol Hsopital Center
-
Contact:
- Théodore Vinais, Master degree
- Phone Number: +33 + 5-87-50-91-29
- Email: theodore.vinais@ch-esquirol-limoges.fr
-
Contact:
- Aude Paquet, PhD in Psychology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Participants will be enrolled from the Deniker unit in the Esquirol Hospital Center of Limoges, France.
This study may involve a vulnerable population. In psychiatric settings, calming rooms are typically installed in closed units that admit crisis patients. These individuals may be hospitalized involuntarily or be under protective measures. Since the study focuses on individuals who are able to use such devices within the participating unit, they can be considered vulnerable.
Description
Inclusion Criteria:
- Gender and Age: Male or female, aged 18 to 65
- Hospitalization: Admitted to the closed hospitalization unit for less than 10 days
- Social security: Affiliated or beneficiary of a social security system
- Consent: Free, informed, and written consent, signed by the participant and/or their legal representative (for participants under protection measures) and the investigator (at the latest on the day of inclusion and before any research-related examination).
Exclusion Criteria:
- Inability to understand information related to the study
- Proven sensory disability
- Dementia
- Pregnancy
- Lack of social protection
- Previous Participation in this research protocol (in the case of a new hospitalization)
- Expression abilities incompatible with completing the AASP Scale (e.g., french language comprehension issues, mute individuals, patients in restraint and/or therapeutic isolation)
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Scores of Sensory Sensitivity from the Adolescent/Adult Sensory Profile (Brown and Dunn, 2002) for users of the calming room and non-users of the calming room
Time Frame: At enrollment
|
The sensory profile scores will be obtained through the Adolescent/Adult Sensory Profile (AASP) scale during an individual interview following the participant inclusion.
The following Sensory Sensitivity sub-score will be collected.
The minimum and maximum values are from 15 to 75.
A high score indicate a high sensory sensitivity.
|
At enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Scores of the Low Registration from the Adolescent/Adult Sensory Profile (Brown and Dunn, 2002) for users of the calming room and non-users of the calming room
Time Frame: At enrollment
|
The sensory profile scores will be obtained through the Adolescent/Adult Sensory Profile (AASP) scale during an individual interview following the participant inclusion.
The following Low Registration sub-score will be collected.
The minimum and maximum values are from 15 to 75.
A high score indicate a high Low Registration.
|
At enrollment
|
|
Scores of the Sensation Seeking from the Adolescent/Adult Sensory Profile (Brown and Dunn, 2002) for users of the calming room and non-users of the calming room
Time Frame: At enrollment
|
The sensory profile scores will be obtained through the Adolescent/Adult Sensory Profile (AASP) scale during an individual interview following the participant inclusion.
The following Sensation Seeking sub-score will be collected.
The minimum and maximum values are from 15 to 75.
A high score indicate a high Sensation Seeking.
|
At enrollment
|
|
Scores of the Sensation Avoiding from the Adolescent/Adult Sensory Profile (Brown and Dunn, 2002) for users of the calming room and non-users of the calming room
Time Frame: At enrollment
|
The sensory profile scores will be obtained through the Adolescent/Adult Sensory Profile (AASP) scale during an individual interview following the participant inclusion.
The following Sensation Avoiding sub-score will be collected.
The minimum and maximum values are from 15 to 75.
A high score indicate a high Sensation Avoiding.
|
At enrollment
|
|
Comparison of Adolescent/Adult Sensory Profile score between the user and non-user of the calming room
Time Frame: From enrollment to the end of observation at 2 weeks
|
|
From enrollment to the end of observation at 2 weeks
|
|
Anxiety for users or non-user of the calming room
Time Frame: From enrollment to the end of observation at 2 weeks
|
Anxiety is assessed from the Hamilton Anxiety Rating Scale for users and non-users of the calming room. The overall score ranges from 0 to 60. The generally accepted threshold for significant anxiety is 20. |
From enrollment to the end of observation at 2 weeks
|
|
Frequency of use of the calming room
Time Frame: From enrollment to the end of observation at 2 weeks
|
- Frequency of Calming Room Use during the 14-Day Participation Period: Total number of uses of the room / time (hours)
|
From enrollment to the end of observation at 2 weeks
|
|
Initiative for the use of the calming room
Time Frame: From enrollment to the end of observation at 2 weeks
|
Modes of use of the calming room among patients who use this room. Qualitative measure is used for initiative : Patient initiative or team initiative |
From enrollment to the end of observation at 2 weeks
|
|
Reason for resquesting of the calming room
Time Frame: From enrollment to the end of observation at 2 weeks
|
Modes of use of the calming room among patients who use this room. Qualitative measure is used for reason for resquesting use of the calming room : Anxiety / Sadness / Fatigue / Physical Tension / Seeking Well-being |
From enrollment to the end of observation at 2 weeks
|
|
Autonomy for the use of the calming room
Time Frame: From enrollment to the end of observation at 2 weeks
|
Modes of use of the calming room among patients who use this room. Qualitative measure is used for autonomy for the use of the calming room : Presence of caregiver / Partial autonomy (one-off intervention by a caregiver) / Total autonomy (nocaregiver intervention during the use) |
From enrollment to the end of observation at 2 weeks
|
|
User frenquecy of the calming room
Time Frame: From enrollment to the end of observation at 2 weeks
|
Number of uses of the calming room during the hospitalization
|
From enrollment to the end of observation at 2 weeks
|
|
Description of anxiety leading to the use of the calming room among patients who use this room.
Time Frame: From enrollment to the the end of observation at 2 weeks
|
Description of early clinical signs leading to the use of the calming room among patients who use this room. Visual Analog Score for anxiety |
From enrollment to the the end of observation at 2 weeks
|
|
Description of well-being leading to the use of the calming room among patients who use this room.
Time Frame: From enrollment to the the end of observation at 2 weeks
|
Description of early clinical signs leading to the use of the calming room among patients who use this room. - Visual Analog Score for well-being |
From enrollment to the the end of observation at 2 weeks
|
|
Description of physical tension leading to the use of the calming room among patients who use this room.
Time Frame: From enrollment to the the end of observation at 2 weeks
|
Description of early clinical signs leading to the use of the calming room among patients who use this room. - Visual Analog Score for physical tension |
From enrollment to the the end of observation at 2 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EVAL-APAISE
- 2023-A00580-45 (Registry Identifier: ID-RCB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.